Literature DB >> 12007454

Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects.

Handan Gunduz1, Huwei Wu, Manzar Ashtari, Bernhard Bogerts, David Crandall, Delbert G Robinson, Jose Alvir, Jeffrey Lieberman, John Kane, Robert Bilder.   

Abstract

BACKGROUND: Previous studies suggest that dysfunction of cortico-striato-pallido-thalamic (CSPT) circuitry may be involved in the pathophysiology of schizophrenia but also show that basal ganglia structure is highly plastic and may be influenced by antipsychotic treatments. Controversy remains about whether basal ganglia pathology can be detected in vivo among treatment-naïve patients. We conducted a magnetic resonance imaging (MRI) study to examine basal ganglia structures and the limbic forebrain in first episode schizophrenia and healthy comparison subjects.
METHODS: Fifty-one patients with first-episode schizophrenia and 28 healthy comparison subjects participated in the study. A high-resolution, special contrast (white matter nulling) MRI sequence was used to measure the caudate nucleus, nucleus accumbens, putamen, and subcommissural limbic forebrain.
RESULTS: Volumes of the basal ganglia regions of interest (adjusted for total brain volume and age) did not differ significantly between the groups. Age correlated significantly with caudate and putamen volumes bilaterally in the healthy comparison group, but not among patients.
CONCLUSIONS: The findings suggest that there are no volumetric abnormalities in basal ganglia before treatment in first-episode schizophrenia. The lack of a negative correlation between age and striatal volume among patients may implicate illness-associated factors that alter normal age-related changes in basal ganglia size.

Entities:  

Mesh:

Year:  2002        PMID: 12007454     DOI: 10.1016/s0006-3223(01)01345-2

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  27 in total

1.  Prefrontal and striatal volumes in monozygotic twins concordant and discordant for schizophrenia.

Authors:  Ulrich Ettinger; Anne Schmechtig; Timothea Toulopoulou; Charmaine Borg; Claire Orrells; Sheena Owens; Kazunori Matsumoto; Neeltje E van Haren; Mei-Hua Hall; Veena Kumari; Philip K McGuire; Robin M Murray; Marco Picchioni
Journal:  Schizophr Bull       Date:  2010-06-10       Impact factor: 9.306

2.  Differential aging of the human striatum: longitudinal evidence.

Authors:  Naftali Raz; Karen M Rodrigue; Kristen M Kennedy; Denise Head; Faith Gunning-Dixon; James D Acker
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

Review 3.  [Changes in brain structure caused by neuroleptic medication].

Authors:  H Scherk; P Falkai
Journal:  Nervenarzt       Date:  2004-11       Impact factor: 1.214

4.  In vivo basal ganglia volumetry through application of NURBS models to MR images.

Authors:  Giuseppe Anastasi; Giuseppina Cutroneo; Francesco Tomasello; Sebastiano Lucerna; AntonGiulio Vitetta; Placido Bramanti; Paolo Di Bella; Anna Parenti; Andrea Porzionato; Veronica Macchi; Raffaele De Caro
Journal:  Neuroradiology       Date:  2006-03-28       Impact factor: 2.804

5.  Structural analysis of the basal ganglia in schizophrenia.

Authors:  Daniel Mamah; Lei Wang; Deanna Barch; Gabriel A de Erausquin; Mokhtar Gado; John G Csernansky
Journal:  Schizophr Res       Date:  2006-10-30       Impact factor: 4.939

6.  Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity.

Authors:  Eric Plitman; Raihaan Patel; Jun Ku Chung; Jon Pipitone; Sofia Chavez; Francisco Reyes-Madrigal; Gladys Gómez-Cruz; Pablo León-Ortiz; M Mallar Chakravarty; Camilo de la Fuente-Sandoval; Ariel Graff-Guerrero
Journal:  Neuropsychopharmacology       Date:  2016-06-08       Impact factor: 7.853

7.  Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia.

Authors:  Bjørn H Ebdrup; Birte Glenthøj; Hans Rasmussen; Bodil Aggernaes; Annika R Langkilde; Olaf B Paulson; Henrik Lublin; Arnold Skimminge; William Baaré
Journal:  J Psychiatry Neurosci       Date:  2010-03       Impact factor: 6.186

8.  Basal ganglia anatomy and schizophrenia: the role of antipsychotic treatment.

Authors:  E Zampieri; M Bellani; B Crespo-Facorro; P Brambilla
Journal:  Epidemiol Psychiatr Sci       Date:  2014-10-22       Impact factor: 6.892

9.  Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia.

Authors:  Martina Ballmaier; Florian Schlagenhauf; Arthur W Toga; Jürgen Gallinat; Michael Koslowski; Michele Zoli; Cornelius Hojatkashani; Katherine L Narr; Andreas Heinz
Journal:  Schizophr Res       Date:  2008-09-24       Impact factor: 4.939

10.  Atrophy of basal ganglia nuclei and negative symptoms in temporal lobe epilepsy.

Authors:  Elizabeth K Geary; Michael Seidenberg; Bruce Hermann
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.